Leadd B.V.

City:

Leiden

Country:

Netherlands

Published Applications:

Last publication date:

2010-11-04

Patent Grants:

Last grant date:

2010-06-22

Top Inventors for applications by Leadd B.V.

These are the the leading inventors for applications assigned to Leadd B.V.:

Jennifer Leigh Rohn 6 Amsterdam, Netherlands
Mathieu Hubertus M. Noteborn 4 Leiderdorp, Netherlands
Astrid Adriana A. M. Danen-van Oorschot 3 Berkel en Rodenrijs, Netherlands
Bertram Weiss 3 Berlin, Germany

Luisella TOSCHI 3 Berlin, Germany
Mathieu Hubertus Maria Noteborn 3 Leiderdorp, Netherlands
Dominik Mumberg 2 Berlin, Germany
Peter Donner 2 Berlin, Germany

Astrid Adriana A.M. Danen-van Oorschot 2 Berkel en Rodenrijs, Netherlands
Matheus Hubertus Maria Noteborn 2 Leiderdorp, Netherlands
Guus Koch 1 Lelystad, Netherlands
Astrid Adriana Anna Maria Danen-Van Oorschot 1 Berkell en Rodenrijs, Netherlands

Mathieu Hubertus Maria Noteborn 1 Leiden, Netherlands
Alexandra Maria Pietersen 1 Leiden, Netherlands

Recent patent applications by Leadd B.V.

Leadd B.V. based in Leiden, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2010-11-04

US20100279947A1

Chemistry; metallurgy

Modifications of apoptin

#2 | 2008-05-01

US20080103099A1

Human necessities

Apoptin-associating protein

#3 | 2008-03-06 ✅ Patent 7,741,440 granted on 2010-06-22

US20080058267A1

Human necessities

Apoptin-associating protein

#4 | 2008-01-15 ✅ Patent 7,319,034 granted on 2008-01-15

US10083849

Modifications of apoptin

#5 | 2008-01-08 ✅ Patent 7,317,096 granted on 2008-01-08

US9655109

Apoptin-associating proteins

#6 | 2007-08-14 ✅ Patent 7,256,274 granted on 2007-08-14

US9733416

Apoptin-associating protein

#7 | 2007-08-07 ✅ Patent 7,253,150 granted on 2007-08-07

US9403213

Gene delivery vehicle expressing the aptosis-inducing proteins VP2 and/or apoptin

#8 | 2005-05-12 ✅ Patent 7,427,658 granted on 2008-09-23

US20050100552A1

Chemistry; metallurgy

Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor

#9 | 2005-04-12 ✅ Patent 6,878,692 granted on 2005-04-12

US9819308

Apoptin-associating protein

AssigneeID:

226318 ⎘